XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Shareholders' Equity (Deficit) (Details) - USD ($)
6 Months Ended
Jul. 12, 2022
Jul. 29, 2023
Apr. 29, 2023
Shareholders' Equity [Abstract]      
Proceeds from equity   $ 7,100,000  
Offering expenses   $ 900,000  
Outstanding Warrants to Purchase Common Stock [Abstract]      
Number Outstanding (in shares)     2,782,286
PIPE Purchase Agreement [Member]      
Shareholders' Equity [Abstract]      
Proceeds from issuance of private placement $ 6,000,000    
PIPE Purchase Agreement [Member] | Pre-Funded Warrants [Member]      
Shareholders' Equity [Abstract]      
Warrant exercisable (in shares) 1    
Outstanding Warrants to Purchase Common Stock [Abstract]      
Exercise Price (in dollars per share)     $ 0.01
Number Outstanding (in shares) 1,818,182   325,126
PIPE Purchase Agreement [Member] | Investor Warrants [Member]      
Shareholders' Equity [Abstract]      
Warrant exercisable (in shares) 1    
Share price (in dollars per share) $ 3.3    
Warrants exercise price (in dollars per share) $ 3.13    
Warrants expiration period   5 years  
Outstanding Warrants to Purchase Common Stock [Abstract]      
Exercise Price (in dollars per share)     $ 3.13
Number Outstanding (in shares)     2,457,160
Registered Purchase Agreement [Member]      
Shareholders' Equity [Abstract]      
Warrants exercise price (in dollars per share)   $ 2.77  
Proceeds from equity $ 2,000,000    
Intrinsic value of warrants   $ 60,000  
Weighted average remaining term of warrants   4 years  
Registered Purchase Agreement [Member] | Pre-Funded Warrants [Member]      
Shareholders' Equity [Abstract]      
Warrant exercisable (in shares) 1    
Outstanding Warrants to Purchase Common Stock [Abstract]      
Number Outstanding (in shares) 638,978